Efficacy, durability, and safety of faricimab in diabetic macular edema (DME): one-year results from the phase 3 YOSEMITE and RHINE trials

被引：0
|
作者：
Wells, John A. [1 ]
Wykoff, Charles Clifton [2 ]
Willis, Jeffrey R. [3 ]
Haskova, Zdenka [3 ]
Lin, Hugh [3 ]
Silverman, David [4 ]
Adamis, Anthony P. [3 ]
Ives, Jane [4 ]
Abreu, Francis [3 ]
Basu, Karen [5 ]
Tadayoni, Ramin [6 ,7 ]
机构：
[1] Palmetto Retina Ctr, W Columbia, SC USA
[2] Retina Consultants Houston, Houston, TX USA
[3] Genentech Inc, San Francisco, CA 94080 USA
[4] Roche Prod Ltd, Welwyn Garden City, Herts, England
[5] Roche Prod Ireland Ltd, Dublin, Ireland
[6] Univ Paris, St Louis, France
[7] Fdn Adolphe Rothschild Hosp, Paris, France
来源：
INVESTIGATIVE OPHTHALMOLOGY & VISUAL SCIENCE | 2021年 / 62卷 / 08期
关键词：
D O I：
暂无
中图分类号：
R77 [眼科学];
学科分类号：
100212 ;
摘要：
引用
收藏
页数：3
相关论文
共 50 条
  • [21] Faster time to retinal fluid control with faricimab versus aflibercept in patients with DME in the phase 3 YOSEMITE/RHINE trials
    Pollreisz, Andreas
    Camino, Acner
    Gibson, Kara
    Mar, Florie
    Shildkrot, Eugene
    Tang, Yannan
    Willis, Jeffrey
    Haskova, Zdenka
    INVESTIGATIVE OPHTHALMOLOGY & VISUAL SCIENCE, 2023, 64 (08)
  • [22] Automated Segmentation of Hyperreflective Foci in Diabetic Macular Edema shows Greater Volume Reduction by Faricimab vs Aflibercept in Phase 3 YOSEMITE and RHINE
    Maunz, Andreas
    von Schulthess, Esther
    Patel, Katie M.
    Chakravarthy, Usha
    Bachmeier, Isabel
    Jones, Ian Lloyd
    Cohen, Yaniv
    Gibson, Kara
    Willis, Jeffrey
    Glittenberg, Carl
    Fauser, Sascha
    INVESTIGATIVE OPHTHALMOLOGY & VISUAL SCIENCE, 2023, 64 (09)
  • [23] Faricimab personalised treatment interval dosing dynamics illustrated with patient case profiles: YOSEMITE and RHINE phase 3 diabetic macular oedema trials
    Balaratnasingam, Chandrakumar
    Jaffe, Glenn J.
    Gerendas, Bianca
    Asik, Kemal
    Scheidl, Stefan
    Abreu, Francis
    Silverman, David
    Haskova, Zdenka
    CLINICAL AND EXPERIMENTAL OPHTHALMOLOGY, 2022, 49 (08): : 834 - 835
  • [24] Efficacy, safety, and durability of faricimab in macular edema due to retinal vein occlusion: 72-week results from the BALATON and COMINO trials
    Ghanchi, Faruque
    Abreu, Francis
    Arrisi, Pablo
    Kotecha, Aachal
    Liu, Ying
    Paris, Liliana P.
    Retiere, Anne-Cecile
    Willis, Jeffrey R.
    INVESTIGATIVE OPHTHALMOLOGY & VISUAL SCIENCE, 2024, 65 (07)
  • [25] Faricimab in Neovascular Age-Related Macular Degeneration: 1-Year Efficacy, Safety, and Durability in the Phase 3 TENAYA and LUCERNE Trials
    Khanani, Arshad
    Heier, Jeffrey
    Ruiz, Carlos
    Lin, Hugh
    Silverman, David
    Brittain, Christopher
    Ives, Jane
    Swaminathan, Balakumar
    Basu, Karen
    Wong, Tien
    INVESTIGATIVE OPHTHALMOLOGY & VISUAL SCIENCE, 2021, 62 (08)
  • [26] Efficacy of One-Year Treatment with Aflibercept for Diabetic Macular Edema with Practical Protocol
    Kaiho, Tomomi
    Oshitari, Toshiyuki
    Tatsumi, Tomoaki
    Takatsuna, Yoko
    Arai, Miyuki
    Shimizu, Norihiro
    Sato, Eiju
    Baba, Takayuki
    Yamamoto, Shuichi
    BIOMED RESEARCH INTERNATIONAL, 2017, 2017
  • [27] EFFICACY, SAFETY, AND DURABILITY OF FARICIMAB IN MACULAR OEDEMA DUE TO RETINAL VEIN OCCLUSION: 72-WEEK RESULTS FROM THE PHASE 3 BALATON AND COMINO TRIALS
    Williams, Michael
    Abreu, Francis R.
    Arrisi, Pablo
    Kotecha, Aachal
    Liu, Ying
    Paris, Liliana
    Retiere, Anne-Cecile
    Willis, Jeffrey R.
    EYE, 2024, 38 : 178 - 178
  • [28] Shape Discrimination Hyperacuity (SDH) Improvement After Treatment of Diabetic Macular Edema (DME): One-Year Results of the DRAMA Study
    Wang, Yi-Zhong
    He, Yu-Guang
    Csaky, Karl G.
    Rodriguez, Luis
    Mejia, Paulina
    Zhang, Song
    Bartlett, Michael B.
    INVESTIGATIVE OPHTHALMOLOGY & VISUAL SCIENCE, 2016, 57 (12)
  • [29] One-Year Follow Up Results of Fluocinolone Acetonide Intravitreal Implant for Diabetic Macular Edema (DME) in Highly Treated Eyes
    Dhawlikar, Nisha
    Shah, Sumit P.
    Yarian, David L.
    Prenner, Jonathan
    Friedman, Eric S.
    Wheatley, H. Matthew
    Fine, Howard F.
    Mantopoulos, Dimosthenis
    Roth, Daniel B.
    INVESTIGATIVE OPHTHALMOLOGY & VISUAL SCIENCE, 2017, 58 (08)
  • [30] Efficacy, Durability and Safety of Faricimab in Neovascular Age-Related Macular Degeneration and Diabetic Macular Oedema: Lessons Learned from Registration Trials
    Helene O. Larsen
    Jakob Grauslund
    Anna S. Vergmann
    Ophthalmology and Therapy, 2023, 12 : 2253 - 2264
12345